Subcutaneous Four-Week Repeated Dose Toxicity Studies of Rice Cell-Derived Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Rats |
Ji, Jung-Eun
(Department of Environmental & Health Chemistry)
Lee, Jung-Min (Department of Environmental & Health Chemistry) Choi, Jong-Min (Department of Environmental & Health Chemistry) Choi, Young-Hwa (Department of Environmental & Health Chemistry) Kim, Eun-Kyung (Department of Environmental & Health Chemistry) Chu, So-Jung (Department of Environmental & Health Chemistry) Kim, Seok-Kyun (Department of Environmental & Health Chemistry) Ahn, Kyong-Hoon (Department of Environmental & Health Chemistry) Lee, Dong-Hoon (Department of Environmental & Health Chemistry) Kim, Ha-Hyung (Physical Pharmacy Laboratory, College of Pharmacy, Chung-Ang University) Han, Kyu-Boem (Hanson Biotech Co., Ltd) Kim, Dae-Kyong (Department of Environmental & Health Chemistry) |
1 | Armitage, J.O. (1998). Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 92, 4491-4508 |
2 | Kim, H.J., Lee, D.H., Kim, D.K., Han G.B. and Kim, H.J. (2008). The glycosylation and in vivo stability of human granulocyte-macrophage colony-stimulating factor produced in rice cells. Biol. Pharm. Bull., 31, 290-294 DOI ScienceOn |
3 | Song, Z.P., Lu, B.R., Zhu, Y.G. and Chen, J.K. (2003). Gene flow from cultivated rice to the wild species Oryza rufipogon under experimental field conditions. New Phytol., 157, 657-665 DOI ScienceOn |
4 | Vazquez, J.A., Gupta, S. and Villanueva, A. (1998). Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal candidiasis in AIDS patients. Eur. J. Clin. Microbiol. Infect. Dis., 17, 781-783 DOI |
5 | Metcalf, D. (1991). Control of granulocytes and macropharges: molecular, cellular, and clinical aspects. Science, 254, 529- 533 DOI |
6 | Okamoto, M., Nakai, M., Nakayama, C., Yanagi, H., Matsui, H., Noguchi, H., Namiki, M., Sakai, J., Kadota, K. and Fukui, M. (1991). Purification and characterization of three forms of differently glycosylated recombinant human granulocyte- macrophage colony-stimulating factor. Arch. Biochem. Biophys., 286, 562-568 DOI ScienceOn |
7 | Doran, P. (2000). Foreign protein production in plant tissue cultures. Trends Biotechnol., 11, 199-204 |
8 | Vandekerckhove, J., Damme, J., van Lijsebettens, M., Botterman, J., De Block, M., Vandewiele, M., De Clercq, A., Leemans, J., van Montagu, M. and Krebbers, E. (1989). Enkephalins produced in transgenic plants using modified 2S seed storage proteins. Biotechnology (N.Y.), 7, 929-932 DOI |
9 | Shin, Y.J., Hong, S.Y., Kwon, T.H., Jang, Y.S. and Yang, M.S. (2003). High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. Biotechnol. Bioeng., 82, 778-783 DOI ScienceOn |
10 | Lee, F., Yokota, T., Otsuka, T., Gemmell, L., Larson, N., Luh, J., Aria, K. and Rennick, D. (1985). Isolation of cDNA for a human granulocyte-macropharge colony-stimulating factor by functional expression in mammalian cells. Proc.Natl. Acad. Sci. USA, 82, 4360-4364 DOI |
11 | Cho, S.A., Park, J.H., Seok, S.H., Juhn, J.H., Kim, S.J., Ji, H.J., Choo, Y.S. and Park, J.H. (2006). Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5- FU-induced ulcerative mucositis in hamster buccal pouches. Exper. Toxicol. Pathol., 57, 321-328 DOI ScienceOn |
12 | Kim, Y.C., Kim, H.J., Kong, M.K., Lim, A.K., Kwon, M.H., Kim, K.S. and Lee, G.D. (2007). Single and four-week repeated oral toxicity study of antidiabetic herb extract microcapsule in sprague-dawley rats. J. Toxicol. Pub. Health, 23, 87-96 과학기술학회마을 DOI ScienceOn |
13 | Krumwieh, D., Weinmann, E., Siebold, B. and Seiler, FR. (1990). Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys. Int. J. Cell Cloning, 8, 229-248 DOI |
14 | Ragnhammar, P., Friesen, H.J., Frodin, J.E., Lefvert, A.K., Hassan, M., Osterborg, A. and Mellstedt, H. (1994). Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients. Blood, 84, 4078-4087 |
15 | Sardana, R., Dudani, A.K., Tackaberry, E., Alli, Z., Porter, S., Rowlandson, K., Ganz, P. and Altosaar, I. (2007). Biologically active human GM-CSF produced in seeds of transgenic rice plants. Transgenic Res., 16, 713-721 DOI |
16 | Lowry, N.J., Rosebrough, A.L., Farr, R.J. and Randall. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275 |
17 | Lieschke, G.J. and Burgess, A.W. (1992). Granulocyte colonystimulating factor and granulocyte-macrophage colonystimulating factor. N. Engl. J. Med., 327, 99-106 DOI ScienceOn |
18 | Wong, G.G., Witek, J.S., Temple, P.A., Wikens, K.M., Leary, A.C., Luxenberg, D.P., Jones, S.S., Brown, E.L., Kay, R.M., Orr, E.C., Shoemaker, C., Golde, D.W., Kaufman, R.J., Hewick, R.M., Wang, E.A. and Clark, S.C. (1985). Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science, 228, 810-815 DOI |
19 | Cantrell, M.A., Anderson, D., Cerretti, D.P., Price, V., Mckereghan, K., Tushinski, R.J., Mochizuki, D.Y., Larsen, A., Grabstein, K., Gillis, S. and Cosman, D. (1985). Cloning, sequencing, and expression of a human granulocyte/macropharge colony-stimulating factor. Proc. Natl. Acad. Sci. USA, 82, 6250-6254 DOI |
20 | Song, S.W., Jung, W. and Hong, D.H. (2006). Thirteen-week repeated-dose toxicity studies of STB-HO-BM in rats. J. Toxicol. Pub. Health, 22, 135-144 과학기술학회마을 |
21 | Ji, J.E., Lee, J.M., Choi, J.M., Choi, Y.H., Kim, S.K., Ahn, K.H., Lee, D.H., Kim, H.H., Han, K.B. and Kim, D.K. (2007). Intravenous single and two week repeated dose toxicity studies of rice cells-derived recombinant human granulocyte-macrophage colony-stimulating factor on rats. J. Toxicol. Pub. Health, 23, 383-389 과학기술학회마을 DOI ScienceOn |
22 | Dorr, R.T. (1993). Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony stimulating factor. Clin. Ther., 15, 19-29 |
23 | Han, J.H., Hesson Chung, Lee, J.H., Suh, J.E., Lee, G.S., Kim, J.C. and Kang, B.H. (2004). Single and two-week repeated oral dose toxicity study of DHP2, a hydrophobic drug delivery vehicle in mice. J. Toxicol. Pub. Health, 20, 123-129 |
24 | Giddings, G. (2001). Transgenic plants as protein factories. Curr. Opin. Biotechnol., 12, 450-454 DOI ScienceOn |
25 | Wadhwa, M., Skog, A.-L., Bird, C., Ragnhammar, P., Liljefors, M., Gaines-Das, R., Mellstedt, H. and Thorpe, R. (1999). Immunogenicity of granulocyte-macrophage colonystimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF. Clin. Cancer Res., 5, 1353-1361 |
26 | Hovgaard, D., Mortensen, B.T., Schifter, S. and Nissen, N.I. (1993). Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor. Eur. J. Haematol., 50, 32-36 |
27 | Rasko, J.E. and Gough, N.M. (1994). Granulocyte-macrophage colony stimulating factor: The cytokine handbook (Thomson, Ed.). Academic Press, London, pp. 343-369 |
![]() |